Microba Life Sciences Limited (ASX:MAP)
Australia
· Delayed Price · Currency is AUD 0.0810
-0.0010 (-1.22%)
At close: Mar 9, 2026
Microba Life Sciences Revenue
Microba Life Sciences had revenue of 7.32M AUD in the half year ending December 31, 2025, with 123.66% growth. This brings the company's revenue in the last twelve months to 14.90M, down -11.81% year-over-year. In the fiscal year ending June 30, 2025, Microba Life Sciences had annual revenue of 15.67M with 29.60% growth.
Revenue (ttm)
14.90M
Revenue Growth
-11.81%
P/S Ratio
3.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
49.33M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| INOVIQ | 2.10M |
| BCAL Diagnostics | 2.54M |
| Cryosite | 15.75M |
| Rhythm Biosciences | 1.65M |
| Genetic Signatures | 19.94M |
| Imagion Biosystems | 73.03K |
| Monash IVF Group | 269.39M |
| Australian Clinical Labs | 737.49M |